Filter by tags: Iodine-131 Canada Clear all tag filters
2 news articles found
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
The supply of Russian radioisotope products to Brazil has allowed the Brazilian government to reduce by half the costs of inputs that help diagnose and treat various cancers, according to Jair Mengatti, production director of Brazil's Institute of Energy and Nuclear Research (IPEN). Over the past years, IPEN, the main producer of radiopharmaceuticals in Brazil, has had problems getting inputs such as Iodine-131, now 100% imported from Russia. "Up until the end of last year, our supplier was from Canada, but after the bidding process, we went to Russia for our supplies. We saved around $100,000 a week," he said.
- Source: NEI Magazine
- Date: Wednesday, 22 June 2016
- Original article: neimagazine.com/news/newsrussia-looks-to-expand-global-radioisotope-supplies-4930195